Mutación por pérdida de función NF1
Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.
| ID | BIO-NF1-MUTATION |
|---|---|
| Tipo | Biomarcador |
| Aliaces | NF1 LOFMutación NF1pérdida de neurofibrominaМутація NF1 (втрата функції) |
| Situación | reviewed 2026-04-29 | pending_clinical_signoff |
| Enfermedades | Ninguna declarada |
| Fuentes | SRC-CIVIC SRC-NCCN-MELANOMA-2025 |
Datos sobre biomarcadores
| Tipo de biomarcador | gene_mutation |
|---|---|
| Detalles de la mutación | {"functional_impact": "loss_of_function", "gene": "NF1", "variant_type": "loss-of-function — frameshift / nonsense / splice / large deletion (germline NF1 syndrome or somatic)"} |
| Medición | MétodoPanel NGS (tumor o gérmenes) detectando truncación / erupción / eventos del CNV; IHC para la pérdida de neurofibromina es sólo de grado de investigación Unidadescategorical (mutated | wild-type) |
| Productos químicos y químicos | BIO-BRAF-V600E |
Notas
NF1 encodes neurofibromin, a RAS-GAP tumor suppressor. Loss-of-function events activate RAS/MAPK signaling. **Melanoma sub-classification (TCGA Cell 2015):** four genomic subtypes — BRAF-mutant, RAS-mutant, NF1-mutant, triple wild-type. NF1-mutant melanomas (~14%) are typically: - cutaneous, sun-exposed sites with high UV signature mutational burden - older patients - frequently co-occur with RASopathy-pattern alterations - generally lack canonical BRAF V600 / NRAS Q61 drivers **Therapeutic relevance:** - No tumor-type-agnostic NF1-directed targeted therapy approved (2026). - MEK inhibitor sensitivity reported in plexiform neurofibroma (selumetinib FDA-approved for pediatric NF1 plexiform NF, 2020) and explored in NF1-mutant cutaneous melanoma (off-label, evidence emerging). - High TMB common in UV-driven NF1-mutant melanoma → ICI candidate. Outside melanoma: NF1 mutation is the defining lesion in neurofibromatosis type 1 (germline) and recurs somatically in glioblastoma, MPNST, juvenile myelomonocytic leukemia (JMML), AML, ovarian, lung adenocarcinoma. Lineage drives interpretation. multi_allele_mvp skip-reason: tumor-suppressor with no single canonical actionable variant — many...
Utilizado por
No se encuentran referencias inversas en el corpus YAML.